Revista Colombiana de Matemáticas,
Journal Year:
2022,
Volume and Issue:
55(2), P. 177 - 196
Published: May 18, 2022
This
paper
presents
a
stability
analysis
of
differential
equations
model
related
to
the
cancer
treatment
with
an
oncolytic
virus
in
its
classical
and
fractional
version
via
Caputo
derivatives.
Numerical
simulations
three
possible
scenarios
are
presented
support
discussions
on
advantages
using
modeling.
Journal of Hematology & Oncology,
Journal Year:
2021,
Volume and Issue:
14(1)
Published: April 16, 2021
Bispecific
T
cell
engagers
(BiTEs)
are
an
innovative
class
of
immunotherapeutics
that
redirect
cells
to
tumor
surface
antigens.
While
efficacious
against
certain
hematological
malignancies,
limited
bioavailability
and
severe
toxicities
have
so
far
hampered
broader
clinical
application,
especially
solid
tumors.
Another
emerging
cancer
immunotherapy
oncolytic
viruses
(OVs)
which
selectively
infect
replicate
in
malignant
cells,
thereby
mediating
vaccination
effects.
These
oncotropic
can
serve
as
vectors
for
tumor-targeted
immunomodulation
synergize
with
other
immunotherapies.
In
this
article,
we
discuss
the
use
OVs
overcome
challenges
BiTE
therapy.
We
review
current
state
field,
covering
published
preclinical
studies
well
ongoing
investigations.
systematically
introduce
OV-BiTE
vector
design
characteristics
evidence
immune-stimulating
anti-tumor
Moreover,
address
additional
combination
regimens,
including
CAR
immune
checkpoint
inhibitors,
further
strategies
modulate
microenvironment
using
OV-BiTEs.
The
inherent
complexity
these
novel
therapeutics
highlights
importance
translational
research
correlative
early-phase
trials.
More
broadly,
OV-BiTEs
a
blueprint
diverse
OV-based
iScience,
Journal Year:
2022,
Volume and Issue:
25(6), P. 104395 - 104395
Published: May 13, 2022
Oncolytic
viruses
(OVs)
are
emerging
cancer
immunotherapy.
Despite
notable
successes
in
the
treatment
of
some
tumors,
OV
therapy
for
central
nervous
system
cancers
has
failed
to
show
efficacy.
We
used
an
ex
vivo
tumor
model
developed
from
human
glioblastoma
tissue
evaluate
infiltration
herpes
simplex
rQNestin
(oHSV-1)
into
tumors.
next
leveraged
our
data
develop
a
computational,
dynamics
that
accounts
cellular
interactions
within
tumor.
Using
computational
model,
we
found
low
stromal
density
was
highly
predictive
oHSV-1
therapeutic
success,
suggesting
efficacy
may
be
determined
by
stromal-to-tumor
cell
regional
density.
validated
these
findings
heterogenous
patient
samples
brain
metastatic
adenocarcinoma.
Our
integrated
modeling
strategy
can
applied
suggest
mechanisms
responses
and
facilitate
successful
translation
OVs
clinic.
Mathematics,
Journal Year:
2025,
Volume and Issue:
13(5), P. 744 - 744
Published: Feb. 25, 2025
This
article
is
concerned
with
the
mathematical
modeling
of
cancer
virotherapy,
emphasizing
impact
Allee
effects
on
tumor
cell
growth.
We
propose
a
framework
that
describes
complex
interaction
between
cells
and
oncolytic
viruses.
The
efficacy
this
therapy
against
mathematically
investigated.
analysis
involves
linear
logistic
growth
scenarios
coupled
different
effects,
including
weak,
strong,
hyper
forms.
Critical
points
are
identified,
their
existence
stability
analyzed
using
dynamical
system
theories
bifurcation
techniques.
Also,
diagrams
numerical
simulations
utilized
to
verify
extend
analytical
results.
It
observed
significantly
influence
conditions
necessary
for
control
eradication.
Mathematical Biosciences & Engineering,
Journal Year:
2022,
Volume and Issue:
19(5), P. 4429 - 4457
Published: Jan. 1, 2022
Combining
chimeric
antigen
receptor
T
(CAR-T)
cells
with
oncolytic
viruses
(OVs)
has
recently
emerged
as
a
promising
treatment
approach
in
preclinical
studies
that
aim
to
alleviate
some
of
the
barriers
faced
by
CAR-T
cell
therapy.
In
this
study,
we
address
means
mathematical
modeling
main
question
whether
single
dose
or
multiple
sequential
doses
during
OVs
therapy
can
have
synergetic
effect
on
tumor
reduction.
To
end,
propose
an
ordinary
differential
equations-based
model
virus-induced
synergism
investigate
potential
effects
different
regimes
could
result
efficacious
combination
against
populations.
Model
simulations
show
that,
while
is
inadequate
eliminate
all
cells,
combining
same
successfully
absence
synergism.
However,
presence
synergism,
fails
tumor.
Furthermore,
it
shown
if
intensity
synergy
and/or
virus
potency
high,
then
induced
response
inhibit
oncolysis.
Additionally,
more
robust
synergistic
reduction
when
and
are
administered
simultaneously
compared
where
first
after
OV
injection.
Our
findings
suggest
seems
unlikely
be
effective
included
genetically
engineering
viral
vectors.
Mathematical Biosciences & Engineering,
Journal Year:
2022,
Volume and Issue:
19(6), P. 6157 - 6185
Published: Jan. 1, 2022
<abstract><p>In
this
study
we
investigate
computationally
tumour-oncolytic
virus
(OV)
interactions
that
take
place
within
a
heterogeneous
extracellular
matrix
(ECM).
The
ECM
is
viewed
as
mixture
of
two
constitutive
phases,
namely
fibre
phase
and
non-fibre
phase.
multiscale
mathematical
model
presented
here
focuses
on
the
nonlocal
cell-cell
cell-ECM
interactions,
how
these
might
be
impacted
by
infection
cancer
cells
with
OV.
At
macroscale
track
kinetics
cells,
particles
ECM.
microscale
(i)
degradation
degrading
enzymes
(MDEs)
produced
which
further
influences
movement
tumour
boundary;
(ii)
re-arrangement
microfibres
macrofibres
(i.e.,
fibres
at
macroscale).
With
help
new
model,
questions:
whether
infected
cell
fluxes
are
result
local
or
non-local
advection
in
response
to
density;
what
effect
spatial
spread
oncolytic
viruses
outcome
virotherapy.</p></abstract>
Mathematics in Applied Sciences and Engineering,
Journal Year:
2020,
Volume and Issue:
1(3), P. 249 - 273
Published: Sept. 28, 2020
Oncolytic
virus
(OV)
therapy
is
a
promising
treatment
for
cancer
due
to
the
OVs
selective
ability
infect
and
replicate
inside
cells,
thus
killing
them,
without
harming
healthy
cells.
In
this
work,
we
present
new
non-local
multiscale
moving
boundary
model
spatio-temporal
cancer-OV
interactions.
This
explores
an
important
double
feedback
loop
that
links
macro-scale
dynamics
of
cancer-virus
interactions
micro-scale
proteolytic
activity
taking
place
at
tumour
interface.
The
cell-cell
cell-matrix
are
assumed
be
nonlocal,
while
cell-virus
local.
With
help
investigate
computationally
various
scenarios
involving
oncolytic
viruses
(i.e.,
effect
injecting
OV
tumour,
or
outside
it).
Moreover,
different
interaction
strengths
on
success
spreading
throughout
constant
density-dependent
diffusion
coefficients
viral
spread.
Physica Scripta,
Journal Year:
2024,
Volume and Issue:
99(3), P. 035227 - 035227
Published: Feb. 2, 2024
Abstract
Oncolytic
viruses
(OVs)
exploit
characteristics
of
mass
cells
and
tumor-related
reaction
the
body
to
presence
antigen,
lyse
malignant
modulate
tumor
microenvironment.
However,
effective
clinical
utilization
these
powerful
treatment
modules
necessitates
their
logical
control,
especially
in
order
prevent
solid
metastatic
outgrowths.
Hence,
it
is
imperative
develop
methods
protect
a
virus
from
annihilating
surroundings
bloodstream
when
traveling
locations.
Our
article
reports
on
bistability
chaotic
behavior
4D
cancer
virotherapy
model.
We
find
that
unstable,
stable
behaviors
can
appear
model
tuning
some
its
parameters.
With
help
chart
dynamic
parameter
spaces,
numerical
investigations
system’s
are
analyzed
followed
by
discussion
obtained
results.
It
appears
local
transition
change
an
invariant
one-torus
(IT1)
two-torus
(IT2)
counterpart
be
found
system
this
undergoes
Neimark-Saker
(NS)
direction.
As
increasing
rate
immune
effector
enhance,
amount
increases
as
consequence,
dynamics
becomes
with
pronounced
Lyapunov
exponent.
This
result
failure
due
interference
viruses.
also
focus
our
study
deign
ad-hoc
electronic
Field
Programmable
Gate
Arrays
(FPGA)
implementations
virotherapy’s
model,
illustrate